Project Details
Description
Dr. Jain will provide leadership to the Genetic Therapies Working Group (GTWG). The GTWG is composed of people with various expertise who will try to develop guidance for bio-pharmaceutical companies on how genetic therapies should be developed for CF patients.
| Status | Active |
|---|---|
| Effective start/end date | 4/1/21 → 3/31/26 |
Funding
- Cystic Fibrosis Foundation (JAIN21A0-LAD)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.